Nolli ML - Search Results

1

Separation and characterization of nonphosphorylated and serine-phosphorylated urokinase. Catalytic properties and sensitivity to plasminogen activator inhibitor type 1.

Franco P, Mastronicola MR, De Cesare D, Nolli ML, Wun TC, Verde P, Blasi F, Stoppelli MP. Franco P, et al. Among authors: nolli ml. J Biol Chem. 1992 Sep 25;267(27):19369-72. J Biol Chem. 1992. PMID: 1527056 Free article.

2

Phosphorylation of human pro-urokinase on Ser138/303 impairs its receptor-dependent ability to promote myelomonocytic adherence and motility.

Franco P, Iaccarino C, Chiaradonna F, Brandazza A, Iavarone C, Mastronicola MR, Nolli ML, Stoppelli MP. Franco P, et al. Among authors: nolli ml. J Cell Biol. 1997 May 5;137(3):779-91. doi: 10.1083/jcb.137.3.779. J Cell Biol. 1997. PMID: 9151681 Free PMC article.

3

Binding of single-chain prourokinase to the urokinase receptor of human U937 cells.

Cubellis MV, Nolli ML, Cassani G, Blasi F. Cubellis MV, et al. Among authors: nolli ml. J Biol Chem. 1986 Dec 5;261(34):15819-22. J Biol Chem. 1986. PMID: 3023326 Free article.

4

Monoclonal antibodies to human urokinase identify the single-chain pro-urokinase precursor.

Salerno G, Verde P, Nolli ML, Corti A, Szöts H, Meo T, Johnson J, Bullock S, Cassani G, Blasi F. Salerno G, et al. Among authors: nolli ml. Proc Natl Acad Sci U S A. 1984 Jan;81(1):110-4. doi: 10.1073/pnas.81.1.110. Proc Natl Acad Sci U S A. 1984. PMID: 6364130 Free PMC article.

5

Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.

Barnathan ES, Kuo A, Rosenfeld L, Karikó K, Leski M, Robbiati F, Nolli ML, Henkin J, Cines DB. Barnathan ES, et al. Among authors: nolli ml. J Biol Chem. 1990 Feb 15;265(5):2865-72. J Biol Chem. 1990. PMID: 2154462 Free article.

6

Purification and characterization of single-chain urokinase-type plasminogen activator (pro-urokinase) from human A431 cells.

Corti A, Nolli ML, Soffientini A, Cassani G. Corti A, et al. Among authors: nolli ml. Thromb Haemost. 1986 Oct 21;56(2):219-24. Thromb Haemost. 1986. PMID: 3101222

7

The differential glycosylation of human pro-urokinase from various recombinant mammalian cell lines does not affect activity and binding to PAI-1.

Sarubbi E, Nolli ML, Robbiati F, Soffientini A, Parenti F, Cassani G. Sarubbi E, et al. Among authors: nolli ml. Thromb Haemost. 1989 Nov 24;62(3):927-33. Thromb Haemost. 1989. PMID: 2512681

8

Tumor cell-conditioned medium stimulates expression of the urokinase receptor in vascular endothelial cells.

Seghezzi G, Marelli R, Mandriota SJ, Nolli ML, Mazzieri R, Mignatti P. Seghezzi G, et al. Among authors: nolli ml. J Cell Physiol. 1996 Nov;169(2):300-8. doi: 10.1002/(SICI)1097-4652(199611)169:2<300::AID-JCP9>3.0.CO;2-S. J Cell Physiol. 1996. PMID: 8908197

9

A monoclonal antibody that recognizes the receptor binding region of human urokinase plasminogen activator.

Nolli ML, Corti A, Soffientini A, Cassani G. Nolli ML, et al. Thromb Haemost. 1986 Oct 21;56(2):214-8. Thromb Haemost. 1986. PMID: 2433787

10

In vivo angiogenic activity of urokinase: role of endogenous fibroblast growth factor-2.

Ribatti D, Leali D, Vacca A, Giuliani R, Gualandris A, Roncali L, Nolli ML, Presta M. Ribatti D, et al. Among authors: nolli ml. J Cell Sci. 1999 Dec;112 ( Pt 23):4213-21. doi: 10.1242/jcs.112.23.4213. J Cell Sci. 1999. PMID: 10564640

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters